Dynavax Technologies Corp. [NASDAQ: DVAX] traded at a low on Wednesday, posting a -1.78 loss after which it closed the day’ session at $11.01.
The results of the trading session contributed to over 4566723 shares changing hands. Over the past one week, the price volatility of Dynavax Technologies Corp. stands at 2.47% while the volatility over the past one month is 3.37%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for DVAX stock reached $1.44 billion, with 131.04 million shares outstanding and 130.41 million shares in the current float. Compared to the average trading volume of 2.19M shares, DVAX reached a trading volume of 4566723 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Dynavax Technologies Corp. [DVAX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DVAX shares is $24.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DVAX stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for Dynavax Technologies Corp. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on February 01, 2024. While these analysts kept the previous recommendation, JMP Securities raised their target price to Mkt Outperform. The new note on the price target was released on September 27, 2022, representing the official price target for Dynavax Technologies Corp. stock. Previously, the target price had yet another raise to $38, while Goldman analysts kept a Buy rating on DVAX stock.
The Average True Range (ATR) for Dynavax Technologies Corp. is set at 0.34, with the Price to Sales ratio for DVAX stock in the period of the last 12 months amounting to 5.78. The Price to Book ratio for the last quarter was 2.24, with the Price to Cash per share for the same quarter was set at 5.61. Price to Free Cash Flow for DVAX in the course of the last twelve months was 40.84 with Quick ratio for the last quarter at 13.18.
How has DVAX stock performed recently?
Dynavax Technologies Corp. [DVAX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.25. With this latest performance, DVAX shares dropped by -3.34% in over the last four-week period, additionally sinking by -14.98% over the last 6 months – not to mention a drop of -24.02% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DVAX stock in for the last two-week period is set at 47.36, with the RSI for the last a single of trading hit 44.08, and the three-weeks RSI is set at 48.15 for Dynavax Technologies Corp. [DVAX]. The present Moving Average for the last 50 days of trading for this stock 11.04, while it was recorded at 11.28 for the last single week of trading, and 12.27 for the last 200 days.
Dynavax Technologies Corp. [DVAX]: Deeper insight into the fundamentals
Dynavax Technologies Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 13.18 and a Current Ratio set at 14.18.
Earnings analysis for Dynavax Technologies Corp. [DVAX]
With the latest financial reports released by the company, Dynavax Technologies Corp. posted 0.1/share EPS, while the average EPS was predicted by analysts to be reported at -0.01/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.11. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DVAX.
Insider trade positions for Dynavax Technologies Corp. [DVAX]
There are presently around $102.48%, or 102.82%% of DVAX stock, in the hands of institutional investors. The top three institutional holders of DVAX stocks are: BLACKROCK INC. with ownership of 21.9 million shares, which is approximately 16.7308%. DEEP TRACK CAPITAL, LP, holding 10.9 million shares of the stock with an approximate value of $$122.41 million in DVAX stocks shares; and DEEP TRACK CAPITAL, LP, currently with $$105.26 million in DVAX stock with ownership which is approximately 7.1594%.
